Diagnostic imaging contrast agents with extended blood retention
US8394356B2 · kind B2 · utility
0Cited by
56References
107Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2011 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Aug 29, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B6/507
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.